The Law Office of Abe Shainberg Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Cephalon, ...

The Law Office of Abe Shainberg is investigating the Board of Directors of Cephalon, Inc. (Nasdaq: CEPH) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA). Under the terms of the proposed transaction, Cephalon shareholders will receive $81.50 in cash per share for a transaction that has a total enterprise value of approximately $6.8 billion.

The investigation concerns whether the Cephalon Board of Directors breached their fiduciary duties to Cephalon stockholders by failing to adequately shop the Company before entering into this transaction and whether Teva Pharmaceutical Industries Ltd. is underpaying for Cephalon shares. According to Yahoo! Finance, at least one analyst placed a price target for Cephalon stock at $92 per share.

If you own common stock in Cephalon and wish to obtain additional information, please contact Abe Shainberg, Esq. either via email at [e-mail] or by telephone at [phone], or visit http://www.ashainberglaw.com/cephalon-ceph.html.

Mr. Shainberg has expertise in prosecuting investor securities litigation, is a certified and registered arbitrator and mediator involving financial matters, and represents investors in various matters nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.